Provided by Tiger Trade Technology Pte. Ltd.

Abbott Laboratories

96.69
-2.1400-2.17%
Post-market: 96.850.1600+0.17%19:56 EDT
Volume:8.86M
Turnover:862.35M
Market Cap:168.13B
PE:31.29
High:99.45
Open:99.10
Low:96.54
Close:98.83
52wk High:135.45
52wk Low:81.97
Shares:1.74B
Float Shares:1.70B
Volume Ratio:1.22
T/O Rate:0.52%
Dividend:2.48
Dividend Rate:2.56%
EPS(TTM):3.09
EPS(LYR):3.73
ROE:10.58%
ROA:5.33%
PB:3.29
PE(LYR):25.92

Loading ...

Abbott - First European Cases Using Amulet 360 Completed in Germany and Denmark

THOMSON REUTERS
·
Aug 27

Abbott's Next-Generation Amulet 360™ Device Receives Ce Mark to Treat People with Atrial Fibrillation at Risk of Stroke

THOMSON REUTERS
·
Aug 27

Abbott Wins CE Mark for Amulet 360 Left Atrial Appendage Occluder in Europe

Reuters
·
Aug 27

Abbott Laboratories Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Aug 27

US Companies Face Rise in Cyber Attacks

Reuters
·
Aug 26

Piper Sandler Sticks to Their Buy Rating for Abbott Laboratories (ABT)

TIPRANKS
·
Aug 26

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 26

Abbott Laboratories Gets Regulatory Authorization for Dual Glucose-Ketone Sensor

MT Newswires Live
·
Aug 26

FDA Authorizes Abbott's Wearable to Monitor Ketone and Glucose in Diabetes Patients

Reuters
·
Aug 26

Abbott receives FDA authorization for Libre Duo 10 Day system

TIPRANKS
·
Aug 26

Abbott - to Launch Libre Duo 10 Day in U.S. Later This Year

THOMSON REUTERS
·
Aug 26

Abbott Receives FDA Authorization for World's First Dual Glucose-Ketone Sensing Technology for People with Diabetes

THOMSON REUTERS
·
Aug 26

FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood Sugar

Reuters
·
Aug 26

FDA :Granted Marketing Authorization to Abbott Diabetes Care for Libre Duo 10 Day Through De Novo Premarket Review Pathway

THOMSON REUTERS
·
Aug 26

Abbott Laboratories Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 22

Analyst Raises Abbott Price Target to $135 on Strengthening Cancer Diagnostics Growth and Successful Exact Sciences Integration

TIPRANKS
·
Aug 21

Dow Jones Top Company Headlines at 9 am ET: Nvidia in Talks to Invest in Data-Center Power Developer Cloverleaf | Italy's ...

Dow Jones
·
Aug 21

Analysts Offer Insights on Healthcare Companies: Corcept Therapeutics (CORT), Alvotech (ALVO) and Abbott Laboratories (ABT)

TIPRANKS
·
Aug 21

Wells Fargo Keeps Their Buy Rating on Abbott Laboratories (ABT)

TIPRANKS
·
Aug 21

TD Cowen Adjusts Price Target on Abbott Laboratories to $135 From $115, Maintains Buy Rating

MT Newswires Live
·
Aug 21